Stockscreener 앱 받기
6.96
1.16%
0.08
시간 외 거래:
6.91
-0.05
-0.72%
전일 마감가:
$6.88
열려 있는:
$6.9
하루 거래량:
508.06K
Relative Volume:
4.36
시가총액:
$121.01M
수익:
-
순이익/손실:
$-7.29M
주가수익비율:
-6.196
EPS:
-1.1233
순현금흐름:
$-7.00M
1주 성능:
+1.02%
1개월 성능:
+34.88%
6개월 성능:
+75.76%
1년 성능:
+527.03%
1일 변동 폭
$6.66
$7.40
1주일 범위
$5.875
$7.51
52주 변동 폭
$0.64
$7.51
Lixte Biotechnology Holdings Inc Stock (LIXT) Company Profile
명칭
Lixte Biotechnology Holdings Inc
전화
310 203 2902
주소
433 PLAZA REAL, BOCA RATON
Compare LIXT vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LIXT
Lixte Biotechnology Holdings Inc
|
6.96 | 116.84M | 0 | -7.29M | -7.00M | -1.1233 |
VRTX
Vertex Pharmaceuticals Inc
|
458.99 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
607.93 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
892.26 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
282.72 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
157.77 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
Lixte Biotechnology Holdings Inc 주식(LIXT)의 최신 뉴스
From Cancer Drugs to Kilowatts: A NASDAQ Company's Bet on the AI Power Crunch - marketscreener.com
LIXTE Biotechnology sings deal to acquire 100% of NOMAD to meet grid demand - MSN
LIXT Transforms from Biotech to Power Infrastructure Amid AI Dem - GuruFocus
LIXT Enters Agreement to Acquire Nomad Transportable Power Syste - GuruFocus
LIXTE Biotechnology to Acquire NOMAD Transportable Power Systems, Pivots to Energy Storage - MEXC
The New Bottleneck Isn’t Computing Power — It’s Just Power - lincolnjournal.com
Lixte Biotechnology to acquire NOMAD Power Systems - Investing.com
LIXTE Biotechnology to Acquire NOMAD Transportable Power Systems, the Market Leader in Mobile, Utility-Grade Battery Energy Storage Systems (BESS) - The Manila Times
LIXTE Biotechnology Holdings, Inc. to Acquire NOMAD Transportable Power Systems, Inc. and Rebrand as NOMAD Power Solutions - Quiver Quantitative
Mobile grid batteries for AI boom: LIXTE to acquire NOMAD BESS leader - Stock Titan
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
LIXTE to acquire NOMAD Transportable Power Systems for BESS pivot - grafa.com
Lixte Biotechnology Holdings (LIXT) Advances 3.3% as Investors Eye Key Resistance at $7.21Low Vol ETF - newsline.com
Lixte Biotechnology (NASDAQ:LIXT) holders report 5.1% stake in company - Stock Titan
Lixte Biotechnology Holdings, Inc. (LIXT) Stock Price, News, Quote & History - Yahoo! Finance Canada
Lixte Biotechnology Announces At-the-Market Equity Financing - TipRanks
Lixte Biotechnology Raises $16.6 Million in Registered Direct Offering of Stock and Pre-Funded Warrants - TradingView
Lixte (NASDAQ: LIXT) closes $16.6M registered direct stock sale - Stock Titan
Lixte (NASDAQ: LIXT) sells 2.37M shares and 258,859 pre-funded warrants for $16.6M - Stock Titan
Lixte Biotechnology raises $16.6 million in direct offering - Investing.com UK
LIXTE Biotechnology prices $16.6M registered direct offering - MSN
Lixte Biotechnology stock falls after $16.6M capital raise By Investing.com - Investing.com Canada
Lixte Biotechnology stock falls after $16.6M capital raise - Investing.com
Lixte Biotechnology raises $16.6 million in direct offering By Investing.com - Investing.com Australia
Lixte Biotechnology Holdings, Inc. (LIXTW) Stock Price, News, Quote & History - Yahoo! Finance Canada
LIXTE Biotechnology Announces $16,566,027 Registered Direct Offering Priced at the Market Under Nasdaq Rules, Strengthening Balance Sheet for Next Phase of Strategic Growth - The Manila Times
LIXTE Biotechnology Announces $16,566,027 Registered Direct - GlobeNewswire
Lixte Biotechnology Prices $16.6 Million Registered Direct Offering Priced at the Market - Moomoo
LIXTE shifts to AI energy infrastructure, adds Porter to board By Investing.com - Investing.com Australia
LIXTE shifts to AI energy infrastructure, adds Porter to board - Investing.com UK
LIXTE (LIXT) director receives 25,000 RSU equity grant - Stock Titan
LIXTE (LIXT) director Stuart D Porter files Form 3 with no trades - Stock Titan
Lixte shifts from cancer drugs to AI energy infrastructure By Investing.com - Investing.com South Africa
LIXTE Biotechnology Transforms into AI Energy Infrastructure Company, Adds Denham Capital Founder to Board - MEXC
Lixte Biotechnology Converts to AI Energy Infrastructure Platform - Let's Data Science
LIXTE Biotechnology Announces Strategic Transformation Into AI Energy Infrastructure Equipment & Services - Moomoo
Lixte Biotechnology Shifts Strategy to AI Energy Infrastructure - TipRanks
LIXTE Biotechnology Transforms Into AI Energy Infrastructure Company, Appoints Denham Capital’s Stuart D. Porter to Board - Minichart
Lixte Biotechnology Holdings Inc. announced a major strategic transformation, shifting its business focus to the field of artificial intelligence energy infrastructure equipment and services. - Bitget
Lixte shifts from cancer drugs to AI energy infrastructure - Investing.com
Lixte appoints Stuart D. Porter to its Board, term through 2026 annual meeting - TradingView
Lixte Biotechnology Holdings Inc (LIXT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.60%
0.94%
자본화:
|
볼륨(24시간):